Literature DB >> 26126744

Cytosine-type nucleosides from marine-derived Streptomyces rochei 06CM016.

Semiha Çetinel Aksoy1, Ataç Uzel1, Erdal Bedir2.   

Abstract

Rocheicoside A (3), a nucleoside analog possessing a novel 5-(hydroxymethyl)-5-methylimidazolidin-4-one substructure, was isolated from marine-derived actinomycete Streptomyces rochei 06CM016, together with a new (4) and three known compounds. Structures of the new metabolites were elucidated by one-dimensional ((1)H and (13)C) and 2D NMR (COSY, HMQC and HMBC) and HR-TOF-MS analyses. All the metabolites exhibited significant antimicrobial activity. A plausible mechanism was proposed for compound 3's formation from amicetin.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26126744     DOI: 10.1038/ja.2015.72

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  23 in total

1.  Rapid mini-preparation of fungal DNA for PCR.

Authors:  D Liu; S Coloe; R Baird; J Pederson
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Widespread and persistent populations of a major new marine actinomycete taxon in ocean sediments.

Authors:  Tracy J Mincer; Paul R Jensen; Christopher A Kauffman; William Fenical
Journal:  Appl Environ Microbiol       Date:  2002-10       Impact factor: 4.792

Review 3.  The evolving role of natural products in drug discovery.

Authors:  Frank E Koehn; Guy T Carter
Journal:  Nat Rev Drug Discov       Date:  2005-03       Impact factor: 84.694

Review 4.  Bioactive microbial metabolites.

Authors:  János Bérdy
Journal:  J Antibiot (Tokyo)       Date:  2005-01       Impact factor: 2.649

Review 5.  Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America.

Authors:  George H Talbot; John Bradley; John E Edwards; David Gilbert; Michael Scheld; John G Bartlett
Journal:  Clin Infect Dis       Date:  2005-01-25       Impact factor: 9.079

6.  Norplicacetin, a new antibiotic from Streptomyces plicatus.

Authors:  J R Evans; G Weare
Journal:  J Antibiot (Tokyo)       Date:  1977-07       Impact factor: 2.649

Review 7.  Movement of the 3'-end of tRNA through the peptidyl transferase centre and its inhibition by antibiotics.

Authors:  S Kirillov; B T Porse; B Vester; P Woolley; R A Garrett
Journal:  FEBS Lett       Date:  1997-04-14       Impact factor: 4.124

8.  Characterization of the amicetin biosynthesis gene cluster from Streptomyces vinaceusdrappus NRRL 2363 implicates two alternative strategies for amide bond formation.

Authors:  Gaiyun Zhang; Haibo Zhang; Sumei Li; Ji Xiao; Guangtao Zhang; Yiguang Zhu; Siwen Niu; Jianhua Ju; Changsheng Zhang
Journal:  Appl Environ Microbiol       Date:  2012-01-20       Impact factor: 4.792

9.  Oxamicetin, a new antibiotic of bacterial origin. II. Structure of oxamicetin.

Authors:  M Konishi; M Naruishi; T Tsuno; H Tsukiura; H Kawaguchi
Journal:  J Antibiot (Tokyo)       Date:  1973-12       Impact factor: 2.649

Review 10.  Marine natural products and their potential applications as anti-infective agents.

Authors:  Marwa Donia; Mark T Hamann
Journal:  Lancet Infect Dis       Date:  2003-06       Impact factor: 25.071

View more
  5 in total

Review 1.  Nature's combinatorial biosynthesis and recently engineered production of nucleoside antibiotics in Streptomyces.

Authors:  Shawn Chen; William A Kinney; Steven Van Lanen
Journal:  World J Microbiol Biotechnol       Date:  2017-03-04       Impact factor: 3.312

Review 2.  Antimicrobial compounds from marine actinomycetes.

Authors:  Cong Wang; Yuanyu Lu; Shugeng Cao
Journal:  Arch Pharm Res       Date:  2020-07-20       Impact factor: 4.946

Review 3.  Identification and characterization of enzymes involved in the biosynthesis of pyrimidine nucleoside antibiotics.

Authors:  M McErlean; X Liu; Z Cui; B Gust; S G Van Lanen
Journal:  Nat Prod Rep       Date:  2021-07-21       Impact factor: 15.111

Review 4.  Current Status and Future Prospects of Marine Natural Products (MNPs) as Antimicrobials.

Authors:  Alka Choudhary; Lynn M Naughton; Itxaso Montánchez; Alan D W Dobson; Dilip K Rai
Journal:  Mar Drugs       Date:  2017-08-28       Impact factor: 5.118

Review 5.  Marine Pharmacology in 2016-2017: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis and Antiviral Activities; Affecting the Immune and Nervous Systems, and Other Miscellaneous Mechanisms of Action.

Authors:  Alejandro M S Mayer; Aimee J Guerrero; Abimael D Rodríguez; Orazio Taglialatela-Scafati; Fumiaki Nakamura; Nobuhiro Fusetani
Journal:  Mar Drugs       Date:  2021-01-21       Impact factor: 5.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.